This Is What Whales Are Betting On Bristol-Myers Squibb
Portfolio Pulse from Benzinga Insights
Investors with significant capital have shown a bearish stance on Bristol-Myers Squibb (BMY) through options trading. Benzinga's options scanner detected 15 unusual trades, with a slight majority being bearish. The stock is currently trading at $52.72, with analysts providing mixed ratings and price targets around $50-$53.
October 01, 2024 | 6:16 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Bristol-Myers Squibb has seen unusual options activity with a slight bearish sentiment. The stock is currently trading at $52.72, and analysts have mixed ratings with price targets around $50-$53.
The detection of unusual options activity with a slight bearish sentiment suggests potential downward pressure on BMY's stock price. Analysts' mixed ratings and price targets below the current trading price further support a bearish outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100